指南与共识糖尿病

胰岛自身抗体阳性3期前1型糖尿病个体监测共识指南

Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
指南 / 共识 · Diabetologia · 2024-01-01

JDRF联合国际专家与学会制定共识指南,针对筛查发现的胰岛自身抗体阳性(IAb+)儿童和成人,提出疾病进展监测建议,包括确认检测、风险分层、定期血糖评估、教育及心理支持,并强调早期1型糖尿病研究存在显著未满足需求。

要点

  • 内分泌科与初级保健提供者应建立合作,共同照护IAb+个体。
  • IAb+个体初次识别时需用第二份样本确认。
  • 单一IAb+个体进展风险低于多IAb+个体。

核心结论

  • 共识指南强调对IAb+儿童和成人进行疾病进展监测,并指出早期1型糖尿病研究存在显著未满足需求,需进一步研究以提高未来推荐的严谨性并指导临床照护。

研究设计与样本

  • JDRF联合国际专家与学会制定共识指南。

主要发现

  • 筛查可降低3期1型糖尿病诊断时糖尿病酮症酸中毒(DKA)的可能性,且延缓疾病进展的治疗可及性正在显现。
  • 广泛实施筛查将识别大量有风险(确认单一IAb+)或已处于早期(多IAb+)1型糖尿病的IAb+儿童和成人。
  • 这些个体的监测大多将在非专科场所进行。

关键数值与推荐

  • 应促进内分泌科医生与初级保健提供者之间的合作,以照护IAb+个体。
  • IAb+个体初次识别时需使用第二份样本确认。
  • 单一IAb+个体的进展风险低于多IAb+个体。
  • 早期1型糖尿病个体应定期医学监测,包括定期评估血糖水平、定期教育糖尿病和DKA症状以及心理社会支持。
  • 有兴趣的2期1型糖尿病个体应被提供试验参与或已批准疗法的机会。

临床怎么用

  • 内分泌科与初级保健提供者应合作照护IAb+个体。
  • IAb+个体初次识别时需用第二份样本确认。
  • 早期1型糖尿病个体应定期监测血糖、接受糖尿病和DKA症状教育及心理社会支持。
  • 有兴趣的2期1型糖尿病个体应被提供试验参与或已批准疗法的机会。
  • 所有参与监测和照护的卫生专业人员都有责任提供教育。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage 3 type 1 diabetes diagnosis, and emerging availability of therapy to delay disease progression, type 1 diabetes screening programmes are being increasingly emphasised. Once broadly implemented, screening initiatives will identify significant numbers of islet autoantibody-positive (IAb+) children and adults who are at risk of (confirmed single IAb+) or living with (multiple IAb+) early-stage (stage 1 and stage 2) type 1 diabetes. These individuals will need monitoring for disease progression; much of this care will happen in non-specialised settings. To inform this monitoring, JDRF in conjunction with international experts and societies developed consensus guidance. Broad advice from this guidance includes the following: (1) partnerships should be fostered between endocrinologists and primary-care providers to care for people who are IAb+; (2) when people who are IAb+ are initially identified there is a need for confirmation using a second sample; (3) single IAb+ individuals are at lower risk of progression than multiple IAb+ individuals; (4) individuals with early-stage type 1 diabetes should have periodic medical monitoring, including regular assessments of glucose levels, regular education about symptoms of diabetes and DKA, and psychosocial support; (5) interested people with stage 2 type 1 diabetes should be offered trial participation or approved therapies; and (6) all health professionals involved in monitoring and care of individuals with type 1 diabetes have a responsibility to provide education. The guidance also emphasises significant unmet needs for further research on early-stage type 1 diabetes to increase the rigour of future recommendations and inform clinical care.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Phillip M, Achenbach P, Addala A, et al. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetologia. 2024. PMID: 38910151. doi:10.1007/s00125-024-06205-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。